Media stories about Atrion (NASDAQ:ATRI) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Atrion earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 45.3773160434466 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Atrion (ATRI) opened at $635.55 on Tuesday. Atrion has a 52 week low of $454.10 and a 52 week high of $694.00. The firm has a market capitalization of $1,181.94, a PE ratio of 37.92 and a beta of 0.85.

Atrion (NASDAQ:ATRI) last announced its quarterly earnings results on Wednesday, November 8th. The medical instruments supplier reported $4.29 earnings per share for the quarter. Atrion had a return on equity of 18.34% and a net margin of 22.98%. The firm had revenue of $37.90 million during the quarter.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Friday, December 1st will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 0.76%. The ex-dividend date is Thursday, November 30th. Atrion’s payout ratio is 26.59%.

ILLEGAL ACTIVITY NOTICE: “Atrion (ATRI) Receiving Somewhat Positive Media Coverage, Analysis Shows” was first posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at

About Atrion

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

Insider Buying and Selling by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.